Navidea Biopharmaceuticals Inc (NYSE American:NAVB)

0.291
Delayed Data
As of Apr 20
 -0.0085 / -2.84%
Today’s Change
0.29
Today|||52-Week Range
0.68
-18.83%
Year-to-Date
No recent news for Navidea Biopharmaceuticals Inc.

Today’s Trading

Previous close0.30
Today’s open0.30
Day’s range0.29 - 0.30
Volume176,037
Average volume (3 months)314,682
Market cap$62.4M
Data as of 3:55pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+2.22%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-91.76%
P/E ratioNM
Price/Sales32.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CXRXConcordia Internatio...+0.00+0.48%
SPHSSophiris Bio Inc+0.01+0.35%
PTNPalatin Technologies...+0.02+1.52%
NBYNovaBay Pharmaceutic...-0.02-0.48%
Data as of 8:00pm ET, 04/20/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$1.8M
Annual profit (last year)-$14.2M
Net profit margin-758.21%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mike M. Goldberg
CFO, COO, Secretary &
Treasurer
Jed Andrew Latkin
Corporate headquarters
Dublin, Ohio

Forecasts